Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PROMINENT

Financiado

PRECISION MEDICINE PLATFORM IN NEURODEGENERATIVE DISEASE

Neurodegenerative diseases are one of the most important contributors to morbidity and mortality in the elderly. In Europe, over 14 million people are currently living with dementia, at a cost of over 400 billion EUR annually. Com... ver más

30/04/2028

11M€

Presupuesto del proyecto: 11M€

Líder del proyecto

KAROLINSKA INSTITUTET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 16 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-04-25

HORIZON-JU-IHI-2022-01-01: An innovative decision-support syst... ExpectedOutcome:R&I actions to be supported under this topic shall contribute to the following o...

I+D

Cerrada hace 2 años

0% 55% 100%

16 Participantes

1.81M€ | Lider

KLINIKUM DER UNIVERSITAET ZU...

549.63K€ | Participante

FUNDACIO BARCELONABETA BRAIN...

435.88K€ | Participante

STIFTELSEN FINGERS BRAIN HEA...

241.75K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

MES-CoBraD Multidisciplinary Expert System for the Assessment Managem... 6M€ Cerrado

PID2019-104358RB-I00 METODOS PARA EL DIAGNOSTICO Y PRONOSTICO ASISTIDOS POR COMPU... 49K€ Cerrado

DIN2019-010879 Desarrollo de arquitecturas de aprendizaje profundo para el... 61K€ Cerrado

TIN2016-80347-R INTEGRACION DE MODELOS BIOINFORMATICOS, COGNITIVOS Y DE ANAT... 146K€ Cerrado

PID2021-122687OA-I00 MODELO COMPUTACIONAL DEL APRENDIZAJE Y LA DEGENERACION DEL M... 49K€ Cerrado

PID2020-114769RB-I00 MODELOS PARA LA ESCLEROSIS MULTIPLE USANDO DEEP LEARNING EN... 213K€ Cerrado

Duración del proyecto: 60 meses Fecha Inicio: 2023-04-25
Fecha Fin: 2028-04-30

Líder del proyecto

KAROLINSKA INSTITUTET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 11M€

Descripción del proyecto Neurodegenerative diseases are one of the most important contributors to morbidity and mortality in the elderly. In Europe, over 14 million people are currently living with dementia, at a cost of over 400 billion EUR annually. Comorbidities with these conditions are frequent and a major obstacle to optimal diagnosis and management. Recent advances in diagnostic technologies and the advent of disease-modifying therapies (DMT) for Alzheimer’s disease (AD), the most common aetiology of dementia, heralds the beginning of precision medicine in this disease area. PROMINENT will develop a digital platform for precision medicine that will remove barriers that currently exists for leveraging these technological advancements in the routine care of patients with neurodegenerative disorders and co-morbidities. The platform gives clinicians access to prediction models leveraging multimodal diagnostic data automatically derived from multiple sources (imaging repositories, medical records, mobile devices), helping them choose optimal care pathways and improving diagnostic precision. It will provide personalized, relevant and meaningful information on diagnosis and prognosis in a format understandable by patients and care partners. Further, it will support the introduction of new health technologies such as DMT for AD, by ensuring adherence to appropriate use guidelines and facilitating the prospective collection of data on real-world usage, safety and effectiveness. The expected impact of the project is to increase diagnostic accuracy and optimized use of existing and new treatment options. It will empower patients and caregivers by engaging them in more person-centric health care decisions, leading to improved adherence and patient experience. Ultimately this is expected to lead to cost-effective care, improved health outcomes and quality of life.

Conecta tu I+D

Entra hoy

¿Olvide mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores